- Home
- SRTS vs IAE Comparison
SRTS vs IAE Comparison
Compare SRTS & IAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRTS
- IAE
- Stock Information
- Founded
- SRTS 2010
- IAE 2007
- Country
- SRTS United States
- IAE United States
- Employees
- SRTS N/A
- IAE N/A
- Industry
- SRTS Medical/Dental Instruments
- IAE Trusts Except Educational Religious and Charitable
- Sector
- SRTS Health Care
- IAE Finance
- Exchange
- SRTS Nasdaq
- IAE Nasdaq
- Market Cap
- SRTS 75.5M
- IAE 74.3M
- IPO Year
- SRTS 2016
- IAE N/A
- Fundamental
- Price
- SRTS $3.39
- IAE $7.29
- Analyst Decision
- SRTS Strong Buy
- IAE
- Analyst Count
- SRTS 3
- IAE 0
- Target Price
- SRTS $8.00
- IAE N/A
- AVG Volume (30 Days)
- SRTS 215.6K
- IAE 46.3K
- Earning Date
- SRTS 08-07-2025
- IAE 01-01-0001
- Dividend Yield
- SRTS N/A
- IAE 10.21%
- EPS Growth
- SRTS N/A
- IAE N/A
- EPS
- SRTS N/A
- IAE N/A
- Revenue
- SRTS $37,564,000.00
- IAE N/A
- Revenue This Year
- SRTS N/A
- IAE N/A
- Revenue Next Year
- SRTS $33.38
- IAE N/A
- P/E Ratio
- SRTS N/A
- IAE N/A
- Revenue Growth
- SRTS 3.29
- IAE N/A
- 52 Week Low
- SRTS $3.03
- IAE $5.31
- 52 Week High
- SRTS $9.33
- IAE $6.45
- Technical
- Relative Strength Index (RSI)
- SRTS 39.05
- IAE 63.39
- Support Level
- SRTS $3.08
- IAE $6.95
- Resistance Level
- SRTS $3.45
- IAE $7.19
- Average True Range (ATR)
- SRTS 0.20
- IAE 0.08
- MACD
- SRTS 0.01
- IAE 0.01
- Stochastic Oscillator
- SRTS 82.00
- IAE 100.00
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
About IAE Voya Asia Pacific High Dividend Equity Income Fund ING Asia Pacific High Dividend Equity Income Fund of Beneficial Interest
Voya Asia Pacific High Dividend Equity Income Fund is a United States-based diversified, closed-end fund.The investment objective of the fund is to provide a total return through a combination of current income, capital gains, and capital appreciation. To achieve this objective, under normal market conditions, the fund invests in a portfolio of dividend-yielding equity securities of companies located in the Asia Pacific region.